课题基金 / 基金详情

Adjuvant Development Program: Leading to an Opioid Vaccine

Adjuvant Development Program: Leading to an Opioid Vaccine
佐剂开发计划:开发阿片类疫苗
批准号:
10020663
负责人:
OFER LEVY
金额:
$228.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-09-29

项目摘要

项目成果

OFER LEVY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract supports the development of an adjuvant through immunological characterization studies and compound optimization, up to and including IND-enabling studies. The main emphasis will be on testing and further development of the adjuvant for human licensure as a component of a licensed or investigational vaccine to protect against one or more non-HIV disease pathogens relevant to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthma
  • 批准号:
    10435035
  • 项目类别:
  • 资助金额:
    $166.59万
  • 财政年份:
    2022
  • 负责人:
    OFER LEVY
  • 依托单位:
Project 3: In vitro modeling to define mechanisms of childhood vaccine response, susceptibility to respiratory infectious disease and asthma
  • 批准号:
    10589826
  • 项目类别:
  • 资助金额:
    $22.79万
  • 财政年份:
    2022
  • 负责人:
    OFER LEVY
  • 依托单位:
Project 3: In vitro modeling to define mechanisms of childhood vaccine response, susceptibility to respiratory infectious disease and asthma
  • 批准号:
    10435043
  • 项目类别:
  • 资助金额:
    $19.86万
  • 财政年份:
    2022
  • 负责人:
    OFER LEVY
  • 依托单位:
Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthma
  • 批准号:
    10589800
  • 项目类别:
  • 资助金额:
    $154.65万
  • 财政年份:
    2022
  • 负责人:
    OFER LEVY
  • 依托单位:
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    40万元
  • 批准年份:
    2020
  • 负责人:
    Vikrant Gupta
  • 依托单位: